Not looking for an immediate turn around because Macro-Market conditions and retail risk tolerance is severely negative right now. However, this sector has huge potential to be a bullish meme in years ahead. Think of getting into Pot Stocks 2.0 before the moon pumps In 2018–19, the United States Food and Drug Administration (FDA) granted breakthrough therapy...
BTC Benitec Biopharma is sitting now at a key support from which we can expect a bounce. We know that earlier this year they had a 7.5mil offering price to the public of $4.25 per share and that Morgan Stanley has a 5.2% stake in the genetic drug company. Benitec's "proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA...
Look it up. Big merger. Big new market. This company has around 10 clinics that specialize in Ketamine psychadelic therapy. New research is being done in this field and psychadelics have proved to be effective in treating alcoholism. I just bought a bunch, but you do you.